Skip to main content

Advertisement

SpringerLink
Log in

Efficacy of paclitaxel-eluting stent implantation in hemodialysis patients

  • Original Article
  • Published:
Heart and Vessels Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Abstract

Hemodialysis patients were recognized as a high-risk group for restenosis after percutaneous coronary intervention in the era of the bare-metal stent. Recently, sirolimus-eluting stents (SES) have reduced restenosis and target lesion revascularization (TLR); however, it has been reported that their efficacy in hemodialysis patients is limited. The purpose of this study was to investigate whether paclitaxel-eluting stents (PES) improved angiographic outcomes of hemodialysis patients compared with SES. This study is a retrospective cohort study. We analyzed 54 hemodialysis patients with 87 lesions implanted with PES from February 2007 to September 2008, and 49 hemodialysis patients with 68 lesions implanted with SES from August 2004 to January 2007. Angiographic follow-up after 8–10 months was obtained for 59 lesions (67.8%) in the PES group and 43 lesions (63.2%) in the SES group. At baseline, the PES patients had more peripheral artery disease compared with the SES group (66.7 vs. 34.7%; p = 0.0012). There were no significant differences in the angiographic characteristics or procedural index. The binary restenosis rate was lower in lesions implanted with PES than in those with SES (13.6 vs. 39.5%; p = 0.034). Accordingly, the TLR rate was lower in lesions implanted with PES than with SES (9.3 vs. 26.5%; p = 0.041). Our results suggest that PES is more effective than SES in reducing restenosis and TLR in hemodialysis patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Roiron C, Sanchez P, Bouzamondo A, Lechat P, Montalescot G (2006) Drug eluting stents: an updated meta-analysis of randomised controlled trials. Heart 92:641–649

    Article  PubMed  CAS  Google Scholar 

  2. Morice MC, Serruys PW, Sousa JE, Fajadet J, Hayashi EB, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, Molnar F, Falotico R (2002) A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346:1773–1780

    Article  PubMed  CAS  Google Scholar 

  3. Naidu SS, Selzer F, Jacobs A, Faxon D, Marks SD, Johnston J, Detre K, Wilensky RL (2003) Renal insufficiency is an independent predictor of mortality after percutaneous coronary intervention. Am J Cardiol 92:1160–1164

    Article  PubMed  Google Scholar 

  4. Lemos PA, Arampatzis CA, Hoye A, Daemon J, Andrew TL, Ong AT, Saia F, Giessen WJ, McFadden EP, Sianos G, Smits PC, Feyter P, Hofma SH, Domburg RT, Serruys PW (2005) Impact of baseline renal function on mortality after percutaneous coronary intervention with sirolimus-eluting stents or bare metal stents. Am J Cardiol 95:167–172

    Article  PubMed  CAS  Google Scholar 

  5. Jeong YH, Hong MK, Lee CW, Park DW, Kim YH, Kim JJ, Park SW, Park SJ (2008) Impact of significant chronic kidney disease on long-term clinical outcomes after drug-eluting stent versus bare metal stent implantation. Int J Cardiol 125:36–40

    Article  PubMed  Google Scholar 

  6. Rosenbulum MA, Robbins MJ, Farkouh ME, Winston JA, Kim MC (2009) Diminished benefits of drug-eluting stents versus bare metal stents in patients with severe renal insufficiency. Nephron Clin Pract 113:c198–c202

    Article  Google Scholar 

  7. Nakai S, Masakane I, Shigematsu T, Hamano T, Yamagata K, Watanabe Y, Itami N, Ogata S, Kimata N, Shinoda T, Shouji T, Suzuki K, Taniguchi M, Tsuchida K, Nakamoto H, Nishi S, Nishi H, Hashimoto S, Hasegawa T, Hanafusa N, Fujii N, Marubayashi S, Morita O, Wakai K, Wada A, Iseki K, Tsubakihara Y (2009) An overview of regular dialysis treatment in Japan (as of 31 December 2007). Ther Apher Dial 13:457–504

    Article  PubMed  Google Scholar 

  8. Yasuda K, Kasuga H, Aoyama T, Takahashi H, Toriyama T, Kawade Y, Iwashima S, Yamada S, Kawahara H, Maruyama S, Yuzawa Y, Ishii H, Murohara T, Matsuo S (2006) Comparison of percutaneous coronary intervention with medication in the treatment of coronary artery disease in hemodialysis patients. J Am Soc Nephrol 17:2322–2332

    Article  PubMed  Google Scholar 

  9. Yachi S, Tanabe K, Tanimoto S, Aoki J, Nakazawa G, Yamamoto H, Otsuki S, Yagishita A, Kishi S, Nakano M, Taniwaki M, Sasaki S, Nakajima H, Mise N, Sugimoto T, Hara K (2009) Clinical and angiographic outcomes following percutaneous coronary intervention with sirolimus-eluting stents versus bare-metal stents in hemodialysis patients. Am J Kidney Dis 54:299–306

    Article  PubMed  Google Scholar 

  10. Okada T, Hayashi Y, Toyofuku M, Imazu M, Otsuka M, Sakuma T, Ueda H, Yamamoto H, Kohno N (2008) One-year clinical outcomes of dialysis patients after implantation with sirolimus-eluting coronary stents. Circ J 72:1430–1435

    Article  PubMed  Google Scholar 

  11. Ishio N, Kobayashi Y, Takebayashi H, Iijima Y, Kanda J, Nakayama T, Kuroda N, Gregorio J, Kouno Y, Suzuki M, Haruta S, Komuro I (2007) Impact of drug-eluting stents on clinical and angiographic outcomes in dialysis patients. Circ J 71:1525–1529

    Article  PubMed  Google Scholar 

  12. Aoyama T, Ishii H, Toriyama T, Takahashi H, Kasuga H, Murakami R, Amano T, Uetani T, Yasuda Y, Yuzawa Y, Maruyama S, Matsuo S, Matsubara T, Murohara T (2008) Sirolimus-eluting stents vs bare metal stents for coronary intervention in Japanese patients with renal failure on hemodialysis. Circ J 72:56–60

    Article  PubMed  Google Scholar 

  13. Ryan TJ, Faxon DP, Gunnar RM, Kennedy JW, King SB, Loop FD, Peterson KL, Reeves TJ, Williams DO, Winters WL (1988) Guidelines for percutaneous transluminal coronary angioplasty: a report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). Circulation 78:486–502

    Article  PubMed  CAS  Google Scholar 

  14. der Zwet PM, Pinto IM, Serruys PW, Reiber JH (1990) A new approach for the automated definition of path lines in digitized coronary angiograms. Int J Card Imaging 5:75–83

    Article  Google Scholar 

  15. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, Es GA, Steg PG, Morel M, Mauri Laura Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW (2007) Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 115:2344–2351

    Article  PubMed  Google Scholar 

  16. Mehran R, Dangas G, Abizaid AS, Mintz GS, Lansky AJ, Satler LF, Pichard AD, Kent KM, Stone GW, Leon MB (1999) Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation 100:1872–1878

    PubMed  CAS  Google Scholar 

  17. Kasai T, Miyauchi K, Kajimoto K, Kubota N, Kurata T, Hiroyuki Daida (2008) Influence of diabetes on >10-year outcomes after percutaneous coronary intervension. Heart Vessels 23:149–154

    Article  PubMed  Google Scholar 

  18. Rajagopalan S, Dellegrottaglie S, Furniss AL, Gillespie BW, Satayathum S, Lameire N, Saito A, Akiba T, Jadoul M, Ginsberg N, Keen M, Port FK, Mukherjee D, Saran R (2006) Peripheral arterial disease in patients with end-stage renal disease observations from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Circulation 114:1914–1922

    Article  PubMed  Google Scholar 

  19. Wu IW, Hung MJ, Chen YC, Hsu HJ, Chemg WJ, Chang CJ, Wu MS (2010) Ventricular function and all-cause mortality in chronic kidney disease patients with angiographic coronary artery disease. J Nephrol 23:181–188

    PubMed  Google Scholar 

  20. Dibra A, Kastrati A, Mehilli J, Pache J, Schühlen H, von Beckerath N, Ulm K, Wessely R, Dirschinger J, Schömig A (2005) Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients. N Engl J Med 353:663–670

    Article  PubMed  CAS  Google Scholar 

  21. Windecker S, Remondino A, Eberli FR, Juni P, Raber L, Wenaweser P, Togni M, Billinger M, Tüller D, Seiler C, Roffi M, Corti R, Sütsch G, Maier W, Lüscher T, Hess OM, Egger M, Meier B (2005) Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization. N Engl J Med 353:653–662

    Article  PubMed  CAS  Google Scholar 

  22. Schömig A, Dibra A, Windecker S, Mehilli J, de Lezo JS, Kaiser C, Park SJ, Goy JJ, Lee JH, Lorenzo E, Wu J, Jűni P, Pfisterer ME, Meier B, Kastrati A (2007) A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease. J Am Coll Cardiol 50:1373–1380

    Article  PubMed  Google Scholar 

  23. Das P, Moliterno DJ, Charnigo R, Mukherjee D, Steinhubl SR, Sneed JD, Booth DC, Ziada KM (2006) Impact of drug-eluting stents on outcomes of patients with end-stage renal disease undergoing percutaneous coronary revascularization. J Invasive Cardiol 18:405–408

    PubMed  Google Scholar 

  24. Hassani SE, Chu WW, Wolfram RM, Kuchulakanti PK, Xue Z, Gevorkian N, Suddath WO, Satler LF, Kent KM, Pichard AD, Weissman NJ, Waksman R (2006) Clinical outcomes after percutaneous coronary intervention with drug-eluting stents in dialysis patients. J Invasive Cardiol 18:273–277

    PubMed  Google Scholar 

  25. Halkin A, Selzer F, Marroquin O, Laskey W, Detre K, Cohen H (2006) Clinical outcomes following percutaneous coronary intervention with drug-eluting vs bare-metal stents in dialysis patients. J Invasive Cardiol 18:577–583

    PubMed  Google Scholar 

  26. Tamekiyo H, Hayashi Y, Toyofuku M, Ueda H, Sakuma T, Okimoto T, Otsuka M, Imazu M, Kihara Y (2009) Clinical outcomes of sirolimus-eluting stenting after rotational atherectomy. Circ J 73:2042–2049

    Article  PubMed  Google Scholar 

  27. Kuriyama N, Kobayashi Y, Nakayama T, Kuroda N, Komuro I (2006) Images in cardiovascular medicine: damage to polymer of a sirolimus eluting stent. Circulation 114:e586–e587

    Article  PubMed  Google Scholar 

  28. Tanigawa J, Barlis P, Mario C (2008) Heavily calcified coronary lesions preclude strut apposition despite high pressure balloon dilatation and rotational atherectomy: in vivo demonstration with optical coherence tomography. Circ J 72:157–160

    Article  PubMed  Google Scholar 

  29. Mahmud E, Bromberg-Marin G, Palakodeti V, Ang L, Creanga D, DeMaria NA (2008) Clinical efficacy of drug-eluting stent in diabetic patients. J Am Coll Cardiol 51:2385–2395

    Article  PubMed  CAS  Google Scholar 

  30. Patterson C, Mapera S, Li HH, Madamanchi N, Hilliard E, Lineberger R, Herrmann R, Charles P (2006) Comparative effects of paclitaxel and rapamycin on smooth muscle migration and survival role of AKT-dependant signaling. Arterioscler Thromb Vasc Biol 26:1473–1480

    Article  PubMed  CAS  Google Scholar 

  31. Fröbert O, Lagerqvist B, Carlsson J, Lindbäck J, Stenestrand U, James KS (2009) Difference in restenosis rate with different drug-eluting stents in patients with and without diabetes mellitus. J Am Coll Cardiol 53:1660–1667

    Article  PubMed  Google Scholar 

  32. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, Airoldi F, Chieffo A, Montorfano M, Carlino M, Michev I, Corvaja N, Briguori C, Gerckens U, Grube E, Colombo A (2005) Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293:2126–2130

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology, Tokyo Women’s Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 160-0022, Japan

    Michiaki Higashitani, Fumiaki Mori, Norihiro Yamada, Hiroyuki Arashi, Asako Kojika, Hiromi Hoshi, Yuichiro Minami, Junichi Yamaguchi, Takao Yamauchi, Atsushi Takagi, Hiroshi Ogawa & Nobuhisa Hagiwara

Authors
  1. Michiaki Higashitani
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fumiaki Mori
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Norihiro Yamada
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hiroyuki Arashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Asako Kojika
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hiromi Hoshi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yuichiro Minami
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Junichi Yamaguchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Takao Yamauchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Atsushi Takagi
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Hiroshi Ogawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Nobuhisa Hagiwara
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michiaki Higashitani.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Higashitani, M., Mori, F., Yamada, N. et al. Efficacy of paclitaxel-eluting stent implantation in hemodialysis patients. Heart Vessels 26, 582–589 (2011). https://doi.org/10.1007/s00380-010-0110-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00380-010-0110-4

Keywords

Search

Navigation